IMREVITE 600 MG SOL INJ SC CT FA VD TRANS X 5 ML

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1018004170030
  • GGREM 505126070025307
  • Barcode 7908754100096

What the source publishes

Holder
BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA
Active ingredients
NIVOLUMABE
Package
600 MG SOL INJ SC CT FA VD TRANS X 5 ML
Product type
Biológico
Therapeutic class
L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1

Names this record is found by

Complete source data
br:cmed:presentations:505126070025307
{
  "name": "IMREVITE 600 MG SOL INJ SC CT FA VD TRANS X 5 ML",
  "holder": "BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7908754100096"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "505126070025307",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": true,
  "holderTaxId": "56.998.982/0001-07",
  "priceRegime": "Regulado",
  "productName": "IMREVITE",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "600 MG SOL INJ SC CT FA VD TRANS X 5 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "22540.94",
    "icms-12": "25614.71",
    "icms-17": "27157.75",
    "icms-18": "27488.95",
    "icms-19": "27828.32",
    "icms-20": "28176.18",
    "icms-21": "28532.84",
    "icms-22": "28898.63",
    "icms-23": "29273.94",
    "icms-17.5": "27322.35",
    "icms-19.5": "28001.17",
    "icms-20.5": "28353.39",
    "icms-22.5": "29085.09",
    "icms-12-alc": "22870.29",
    "icms-17-alc": "24247.99",
    "icms-18-alc": "24543.70",
    "icms-19-alc": "24846.70",
    "icms-20-alc": "25157.29",
    "icms-21-alc": "25475.75",
    "icms-22-alc": "25802.34",
    "icms-23-alc": "26137.44",
    "withoutTaxes": "20125.84",
    "icms-17.5-alc": "24394.95",
    "icms-19.5-alc": "25001.04",
    "icms-20.5-alc": "25315.50",
    "icms-22.5-alc": "25968.81"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "NIVOLUMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "NIVOLUMABE"
  ],
  "therapeuticClass": "L1G5 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, PD-1/PD-L1",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1018004170030",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1G5",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:505126070025307"